Contact this trialFirst, we need to learn more about you.
Platelet-Rich Plasma System
ACP Max™ for Knee Osteoarthritis
Recruiting1 award7 criteria
Knoxville, Tennessee
This trial will include 45 patients who will be randomly assigned to receive either a single injection of ACP Max™ or Depo-Medrol®. The purpose of this study is to compare the
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service